Meet SmartMed, by Salynt
SmartMed helps neuro-oncology and imaging research teams identify tumor regions, measure change across scans, and bring findings together for review.
Trusted by
Explore three parts of the workflow.
See the full platform in a private demo.
AI-assisted segmentation highlights tumor regions for expert review. Toggle the illustration’s colors to explore how visual emphasis helps distinguish areas of interest.
SmartMed brings volume measurements and study comparisons into the review. Move the slider to explore the idea; these shapes represent no patient data or measured result.
One case. Connected information.
Highlighted regions and the views behind them.
Region volumes and findings across available studies.
Relevant history and supporting information for review.
Bring findings, measurements, and context into the same conversation, with the expert reviewer at the center.
A family emergency brought the challenge of understanding complex brain imaging close to home. It became the starting point for SmartMed.
In this Baltimore Homecoming film, founder Jeremy Lawson shares the story behind the work.
Featured in Baltimore Homecoming · 1 min 20 sec
Our next step is independent clinical evaluation, building on early segmentation benchmarks.
Dice measures segmentation overlap on a scale from 0 to 1. A score of 1.000 represents a perfect match.
BraTS 2021 · nnU-Net baselineSalynt-reported BraTS 2021 baseline. Read the evaluation context below.
Salynt participated in the 2025 fellowship cohort, refined its work through clinician conversations, and earned the Top Technology Award.
We’re preparing a retrospective study focused on adult glioma imaging with Johns Hopkins collaborators. The proposed work will compare SmartMed outputs with expert review.
Study preparation is ongoing. Institutional approvals, data access, and final agreements are being worked through. SmartMed remains a research-stage platform.
Discuss a research collaboration ↗Bringing imaging AI, clinical research, and software engineering together.
10+ years as a data scientist across defense & intelligence (Booz Allen Hamilton, SixGen). TS/SCI-cleared. M.S. Data Science, GWU; B.S. Mathematics, Jackson State University. Fellow, Johns Hopkins Medicine Ward Infinity.
IT & operations leader. Formerly U.S. Department of State and CNN (WarnerMedia). GWU & MIT. Fellow, Johns Hopkins Medicine Ward Infinity.
CEO of CypherIntel and Salynt investor/advisor, bringing cybersecurity, intelligence, and enterprise technology perspective to support Salynt's growth, strategic positioning, and trusted AI infrastructure.
Former NASA and White House (Obama Administration), and McKinsey. Multi-exit startup leader who has advised 50+ founders scaling to nine-figure revenues.
Choose what you’d like to discuss, and we’ll connect you with the right conversation.
info@salynt.ioStories, milestones, and the next chapter of our work.
How a personal experience led to SmartMed and the pursuit of independent clinical evidence.
Salynt is listed among the companies representing Maryland at the MedTech Conference.
Coverage of the fellowship showcase and pitch competition featuring Salynt.
A look at the experience and perspective behind our work in AI.
Explore the Baltimore healthcare company directory on F6S.
Read the July edition of our newsletter.
Showing all 6 updates
